Lonza · 1 month ago
Finance Transformation Lead
Lonza is a global leader in life sciences operating across five continents, seeking a Finance Transformation Lead to support the transformation of the A2D workstream within the organization's SAP S/4HANA ERP implementation. The role focuses on maximizing S/4HANA's capabilities and embedding industry best practices to optimize processes across the company.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Collaborate with stakeholders to define key performance indicators (KPls) and build effective dashboards and reports
Conduct regular meetings in alignment with the Stream Lead. Address issues or concerns raised by local teams
Design and architect future process solutions within the S4/HANA environment, ensuring alignment with business requirements and industry best practices
Manage the end-to-end implementation of Stream related modules within S4/HANA, including reporting
Develop and execute tests to validate that the ERP system meets requirements
Co-Develop training materials and conduct training sessions for key users/ end-users to ensure successful adoption of the S4/HANA solutions
Provide ongoing support and troubleshooting to resolve any post-implementation issues
Qualification
Required
Strong business and finance background. Operational understanding
SAP knowledge – S/4 Hana would be advantageous but not critical
Ability to lead process improvement initiatives
Change management experience
Ability to work in a dynamic environment with tight deadlines
Will require travel depending on project needs for a duration of 2-3 weeks up to x2 times per year
Benefits
An agile career and dynamic working culture
An inclusive and ethical workplace
Hybrid working policy
A variety of benefits tailored to your localality.
Access to global benefits via https://www.lonza.com/careers/benefits
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase